Selinexor and Pembrolizumab for the Treatment of Cisplatin-Ineligible or Cisplatin-Refractory Locally Advanced or Metastatic Urothelial Carcinoma

Name: Selinexor and Pembrolizumab for the Treatment of Cisplatin-Ineligible or Cisplatin-Refractory Locally Advanced or Metastatic Urothelial Carcinoma
License: Public Domain

Mamta Parikh

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced urothelial carcinoma, locally advanced urothelial carcinoma, metastatic urothelial carcinoma, refractory urothelial carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 640560
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.